RaySearch receives first order for DrugLog
RaySearch Laboratories AB (publ) today announces that the Polish company Medim has placed an order for the product DrugLog™. The…
22,450€
-0,66%
Echtzeit-Aktienkurs RaySearch Laboratories AB
Bid:
Ask:
Nachrichten zur RaySearch Laboratories AB Aktie
RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024
RaySearch will be exhibiting its advanced software solutions at RSNA in Chicago, Illinois, December 1 – 4. RSNA is the…
Institut Curie selects RayStation for proton planning
RaySearch Laboratories AB (publ) is pleased to announce that Institut Curie, spread over three radiotherapy centers, located in Paris, Orsay,…
RaySearch appoints new CFO
RaySearch Laboratories AB (publ) announces that Nina Grönberg has been appointed new CFO of the company, taking up her position…
Another three centers under the French Unicancer framework select RayStation
RaySearch Laboratories AB (publ) is pleased to announce that Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier…
RaySearch has more than 100 RayStation customers in China
RaySearch Laboratories AB (publ) is proud to announce that the number of radiotherapy centers in China using RayStation®* for treatment…
GenesisCare UK selects RayStation
RaySearch Laboratories AB (publ) is pleased to announce that GenesisCare UK has placed an order for the RayStation®* treatment planning…
RaySearch’s CEO sells shares – remains a long-term shareholder
RaySearchs founder and CEO, Johan Löf, has sold 150,000 Class B shares in RaySearch Laboratories AB (publ) on September 24,…
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
RaySearch Laboratories AB (publ) is pleased to announce that Iridium Network in Belgium has treated its first patient using RaySearch’s…
Connecticut Proton Therapy Center selects RayCare
RaySearch Laboratories AB (publ) is pleased to announce that the Connecticut Proton Therapy Center, Wallingford, Connecticut, USA, has placed an…
RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system
RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where RaySearch’s RayStation®* was used for the…
RaySearch celebrating 10 years of defining state-of-the-art proton planning at PTCOG 62
RaySearch Laboratories AB (publ) will kick off its tenth-anniversary celebration at the Particle Therapy Cooperative Group (PTCOG) Conference in Singapore,…
RaySearch releases RayCare 2024A
RaySearch Laboratories AB (publ) announces the release of the latest version of RayCare®*, the next generation oncology information system. RayCare…
Bulletin from the Annual General Meeting 2024
The Annual General Meeting 2024 of RaySearch Laboratories AB (publ) was held on May 22, 2024 in Stockholm, Sweden. The…
RaySearch and C-RAD sign collaboration agreement
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and…
Invitation to Annual General Meeting 2024
The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to…
World leading carbon ion center QST in Japan selects RayStation
RaySearch Laboratories AB (publ) announces that QST, National Institutes for Quantum Science and Technology in Chiba, Japan, has selected the…
RaySearch to present latest innovations in RayStation, RayCare and RayIntelligence at ISOP and NPC (NAPT)
RaySearch Laboratories AB (publ) will present the latest software innovations at IBA’s International Symposium on Proton Therapy (ISOP) in Boston,…